News ResMed Inc. Australian S.E.

Equities

RMD

AU000000RMD6

Delayed Australian S.E. Other stock markets 10:46:22 2024-04-25 pm EDT			5-day change	1st Jan Change
30.6 ^AUD	+6.47%		+9.63%	+20.32%

12:12am	ResMed tops quarterly profit estimates on strong demand for sleep apnea devices	RE
Apr. 25	ResMed Fiscal Q3 Non-GAAP Earnings, Revenue Increase; Shares Rise After Hours	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ResMed tops quarterly profit estimates on strong demand for sleep apnea devices	06:12pm	RE
ResMed : Q3 2024 ResMed Earnings Results Webcast Corporate 1-Pager	06:02pm	PU
ResMed : Q3 2024 ResMed Earnings Results Webcast Presentation	06:02pm	PU
ResMed Fiscal Q3 Non-GAAP Earnings, Revenue Increase; Shares Rise After Hours	Apr. 25	MT
Transcript : ResMed Inc., Q3 2024 Earnings Call, Apr 25, 2024	Apr. 25
ResMed: Fiscal Q3 Earnings Snapshot	Apr. 25	AQ
ResMed Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	Apr. 25	CI
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024	Apr. 25	GL
Wall St set for higher open on megacaps boost; earnings, Fed comments on tap	Apr. 17	RE
ResMed AirSense 10 AutoSet: Empowering Sleep Health with Positive Airway Pressure Therapy	Apr. 16	AQ
ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024	Apr. 04	GL
ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024	Apr. 04	AQ
Needham Adjusts ResMed's Price Target to $224 From $180, Maintains Buy Rating	Apr. 01	MT
ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis	Mar. 15	GL
ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis	Mar. 15	AQ
Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask	Mar. 06	GL
Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask	Mar. 06	AQ
ResMed Inc. Announces the U.S. Launch of the AirFit F40	Mar. 06	CI
Morgan Stanley Adjusts Resmed’s Price Target to AU$31.80 From AU$28.60, Keeps at Overweight	Mar. 05	MT
Evans & Partners Upgrades ResMed to Positive From Neutral, Price Target is AU$31	Mar. 04	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ResMed, Inc. continues to make headway in the sleep market

December 11, 2023 at 05:55 am EST